Iradimed (IRMD) Interest Coverage Ratio Growth (5y) (2018 - 2026)
Iradimed (IRMD) Interest Coverage Ratio Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Iradimed | 1.20 Bn | 1.14 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.88% |
| Dec 31, 2025 | 52.23% |
| Sep 30, 2025 | 45.86% |
| Jun 30, 2025 | 31.48% |
| Mar 31, 2025 | 185.21% |
| Dec 31, 2024 | 48.27% |
| Sep 30, 2024 | 46.10% |
| Jun 30, 2024 | 49.60% |
| Mar 31, 2024 | 88.10% |
| Dec 31, 2023 | -19.54% |
| Sep 30, 2023 | 54.18% |
| Jun 30, 2023 | 104.57% |
| Mar 31, 2023 | 60.28% |
| Dec 31, 2022 | -28.93% |
| Sep 30, 2022 | 93.82% |
| Jun 30, 2022 | 77.30% |
| Mar 31, 2022 | 79.12% |
| Dec 31, 2021 | -7.61% |
| Sep 30, 2021 | 2.41% |
| Jun 30, 2021 | -51.25% |